Back to search
Cannabis-Related Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabis-Related Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabis-Related Disorder trials you may qualify forThe goal of this study is to test a causal neural mechanism of cannabis use-related problem recognition in individuals with severe cannabis use disorder using a…
This study investigates sex differences in reward processing following acute THC administration in adults with cannabis use disorder (CUD). Using multimodal neu…
Cannabis is the most consumed drug in the world and the French are the main consumers in Europe. The most recognized effects of cannabis on human health are of…
This study is testing whether brain activity related to learning can help predict how well teens respond to a treatment program designed to reduce cannabis use.…
This outpatient study examines how cannabidiol (CBD) affects the behavioral and pain-relieving effects of cannabis.
ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, randomised trial to compare the cannabinoid Nabiximols with placebo in patients with r…
Though regulated cannabis sales are increasing, little is known about the individual health effects of cannabis regulation. Data from countries with a regulated…
The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat th…
Posttraumatic stress disorder (PTSD) is a disabling psychiatric disorder that affects 20%-30% of U.S. Veterans. PTSD is strongly associated with increased risk…